In light of the promising evidence regarding the beneficial effects of GLP-1 RAs in glycemic control and weight reduction, their use in diabetic and obese patients, respectively, has increased substantially
Srensen KK, Mller FT, Yazdanfard PDW, et al
It is one of the few research peptides with a direct path to FDA-approved clinical use afamelanotide received FDA approval in 2019 for the treatment of erythropoietic protoporphyria (EPP), a rare genetic photosensitivity disorder
It protects the glutathione from stomach acid and the GGT enzymes in the intestine
Real-world cardiovascular benefits are linked to weight loss, improved blood pressure, and reduced inflammation, Ali notes
This medication operates by slowing down stomach emptying and signaling fullness to the brain, naturally decreasing food intake